LC-Q-TOF-MS/MS determination of darunavir and its metabolites in rat serum and urine: Application to pharmacokinetics

被引:11
作者
Rao, R. Nageswara [1 ]
Prasad, K. Guru [1 ]
机构
[1] Indian Inst Chem Technol, Discovery Lab, Div Analyt Chem, Hyderabad 500607, Andhra Pradesh, India
关键词
Darunavir; Rat serum; Urine; Selective ion monitoring; Pharmacokinetics; REVERSE-TRANSCRIPTASE INHIBITORS; HIV PROTEASE INHIBITORS; LOW-DOSE RITONAVIR; LIQUID-CHROMATOGRAPHY; HUMAN PLASMA; BLOOD; QUANTIFICATION; VALIDATION;
D O I
10.1016/j.jpba.2014.01.035
中图分类号
O65 [分析化学];
学科分类号
070302 ; 081704 ;
摘要
A simple, rapid and reliable liquid chromatography coupled with quadrupole time of flight mass spectrometry (LC-Q-TOF-MS/MS) method was developed and validated for simultaneous determination of darunavir and its metabolites in rat serum and urine. The separation was accomplished on an Agilent RP-18 (250 x 4.6 mm, 5 pm) column using 20 mM ammonium acetate and methanol (40:60, v/v) as a mobile phase at a flow rate of 1.0 mL/min in an isocratic mode. The [M+H](+) ions of darunavir (m/z 548) and metabolites-I (m/z 392) were monitored in positive mode of ionization, while [M-H](-) ion of metabolite-II (m/z 172) in negative mode selectively. The matrix effects of rat serum and urine were found to be negligible and the recoveries were 87-93% for all the analytes. The short and long term stability of darunavir and its metabolites was within acceptable limits and the lower limits of quantification were in the range of 3.63-5.24 ng/mL with a linear range of 5-5000 ng/mL in rat serum as well as urine. The method exhibited good intra- and inter-day performance in terms of 2.54-8.92% precision and 0-5% accuracy. The method was successfully applied to a single-dose pharmacokinetic study of darunavir boosted with ritonavir in Wistar rats. (C) 2014 Elsevier B.V. All rights reserved.
引用
收藏
页码:92 / 98
页数:7
相关论文
共 23 条
[1]   Determination of succinylacetone in dried blood spots and liquid urine as a dansylhydrazone by liquid chromatography tandem mass spectrometry [J].
Al-Dirbashi, OY ;
Rashed, MS ;
Ten Brink, HJ ;
Jakobs, C ;
Filimban, N ;
Al-Ahaidib, LY ;
Jacob, M ;
Al-Sayed, MM ;
Al-Hassnan, Z ;
Faqeih, E .
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES, 2006, 831 (1-2) :274-280
[2]   A review of low-dose ritonavir in protease inhibitor combination therapy [J].
Cooper, CL ;
van Heeswijk, RPG ;
Gallicano, K ;
Cameron, DW .
CLINICAL INFECTIOUS DISEASES, 2003, 36 (12) :1585-1592
[3]   HPLC-MS method for the simultaneous quantification of the new HIV protease inhibitor darunavir, and 11 other antiretroviral agents in plasma of HIV-infected patients [J].
D'Avolio, Antonio ;
Siccardi, Marco ;
Sciandra, Mauro ;
Lorena, Baietto ;
Bonora, Stefano ;
Trentini, Laura ;
Di Perri, Giovanni .
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES, 2007, 859 (02) :234-240
[4]   HPLC-MS method for the quantification of nine anti-HIV drugs from dry plasma spot on glass filter and their long term stability in different conditions [J].
D'Avolio, Antonio ;
Simiele, Marco ;
Siccardi, Marco ;
Baietto, Lorena ;
Sciandra, Mauro ;
Bonora, Stefano ;
Di Perri, Giovanni .
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2010, 52 (05) :774-780
[5]   TMC114, a novel human immunodeficiency virus type 1 protease inhibitor active against protease inhibitor-resistant viruses, including a broad range of clinical isolates [J].
De Meyer, S ;
Azijn, H ;
Surleraux, D ;
Jochmans, D ;
Tahri, A ;
Pauwels, R ;
Wigerinck, P ;
de Béthune, MP .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2005, 49 (06) :2314-2321
[6]   Analysis of cyclosporin A, tacrolimus, sirolimus, and everolimus in dried blood spot samples using liquid chromatography tandem mass spectrometry [J].
den Burger, J. C. G. ;
Wilhelm, A. J. ;
Chahbouni, A. ;
Vos, R. M. ;
Sinjewel, A. ;
Swart, E. L. .
ANALYTICAL AND BIOANALYTICAL CHEMISTRY, 2012, 404 (6-7) :1803-1811
[7]   Validation of a rapid and sensitive high-performance liquid chromatography-tandem mass spectrometry (HPLC-MS/MS) assay for the simultaneous determination of existing and new antiretroviral compounds [J].
Else, Laura ;
Watson, Victoria ;
Tjia, John ;
Hughes, Andrew ;
Siccardi, Marco ;
Khoo, Saye ;
Back, David .
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES, 2010, 878 (19) :1455-1465
[8]   A LC-tandem MS assay for the simultaneous measurement of new antiretroviral agents: Raltegravir, maraviroc, darunavir, and etravirine [J].
Fayet, A. ;
Beguin, A. ;
Zanolari, B. ;
Cruchon, S. ;
Guignard, N. ;
Telenti, A. ;
Cavassini, M. ;
Guenthard, H. F. ;
Buclin, T. ;
Biollaz, J. ;
Rochat, B. ;
Decosterd, L. A. .
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES, 2009, 877 (11-12) :1057-1069
[9]   Quantification of darunavir (TMC 114) in human plasma by high-performance liquid chromatography with ultra-violet detection [J].
Goldwirt, Lauriane ;
Chhun, Stephanie ;
Rey, Elisabeth ;
Launay, Odile ;
Viard, Jean-Paul ;
Pons, Gerard ;
Jullien, Vincent .
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES, 2007, 857 (02) :327-331
[10]   A liquid chromatography-tandem mass spectrometry assay for quantification of nevirapine, indinavir, atazanavir, amprenavir, saquinavir, ritonavir, lopinavir, efavirenz, tipranavir, darunavir and maraviroc in the plasma of patients infected with HIV [J].
Martin, J. ;
Deslandes, G. ;
Dailly, E. ;
Renaud, C. ;
Reliquet, V. ;
Raffi, F. ;
Jolliet, P. .
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES, 2009, 877 (27) :3072-3082